FDA Approves Aristada Initio to Allow Immediate Initiation of the Long-Acting Atypical Antipsychotic
Clinicians will soon be able to offer patients with schizophrenia who are initiating the long-acting...
Clinicians will soon be able to offer patients with schizophrenia who are initiating the long-acting...
